Advertisement

Topics

Silvergate Pharmaceuticals announces Xatmep availability

16:11 EDT 31 Jul 2017 | Drug Store News
The drug, approved by the Food and Drug Administration in April, is indicated to treat acute lymphoblastic leukemia and manage polyarticular juvenile idiopathic arthritis in pediatric patients.

read more

Original Article: Silvergate Pharmaceuticals announces Xatmep availability

NEXT ARTICLE

More From BioPortfolio on "Silvergate Pharmaceuticals announces Xatmep availability"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...